Biomedical Engineering Reference
In-Depth Information
70. Woolhouse IS, Bayley DL, Stockley RA. Sputum chemotactic activity in
chronic obstructive pulmonary disease: effect of alpha(l)-antitrypsin deficiency
and the role of leukotriene B(4) and interleukin 8. Thorax 2002; 57:709-714.
71. Aaron SD, Angel JB, Lunau M, Wright K, Fex C, Le Saux N, et al. Granu-
locyte inflammatory markers and airway infection during acute exacerbation
of chronic obstructive pulmonary disease. Am J Respir Crit Care Med
2001; 163:349-355.
72. Gompertz S, O'Brien C, Bayley DL, Hill SL, Stockley RA. Changes in bron-
chial inflammation during acute exacerbations of chronic bronchitis. Eur
Respir J 2001; 17:1112-1119.
73. Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. Association between
airway bacterial load and markers of airway inflammation in patients with
stable chronic bronchitis. Am J Med 2000; 109:288-295.
74. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha
JA. Relationship between bacterial colonisation and the frequency, character,
and severity of COPD exacerbations. Thorax 2002; 57:759-764.
75. Nocker RE, Schoonbrood DF, Van de Graaf EA, Hack CE, Lutter R, Jansen
HM, et al. Interleukin-8 in airway inflammation in patients with asthma and
chronic obstructive pulmonary disease. Int Arch Allergy Immunol 1996;
109:183-191.
76. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway inflam-
mation and bronchial microbial patterns in patients with stable chronic
obstructive pulmonary disease. Eur Respir J 1999; 14:1015-1022.
77. Tanino M, Betsuyaku T, Takeyabu K, Tanino Y, Yamaguchi E, Miyamoto
K, et al. Increased levels of interleukin-8 in BAL fluid from smokers suscep-
tible to pulmonary emphysema. Thorax 2002; 57:405-411.
78. Nakamura H, Yoshimura K, Jaffe HA, Crystal RG. Interleukin-8 gene
expression in human bronchial epithelial cells. J Biol Chem 1991; 266:
19611-19617.
79. Nakamura H, Yoshimura K, Jaffe HA, Crystal RG. Transcriptional regula-
tion of interleukin-8 gene expression by tumor necrosis factor-
a
in bronchial
epithelial cells. Am Rev Respir Dis 1991; 143:A201.
80. Kwon OJ, Au BT, Collins PD, Adcock IM, Mak JC, Robbins RA, et al.
Tumor necrosis factor-induced interleukin 8 expression in cultured human
epithelial cells. Am J Physiol 1994; 11:L398-L405.
81. de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra
PS. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways
inflammation in COPD. J Pathol 2000; 190:619-626.
82. Schulz C, Wolf K, Harth M, Kratzel K, Kunz-Schughart L, Pfeifer M.
Expression and release of interleukin-8 by human bronchial epithelial cells
from patients with chronic obstructive pulmonary disease, smokers, and
never-smokers. Respiration 2003; 70:254-261.
83. Profita M, Chiappara G, Mirabella F, Di Giorgi R, Chimenti L, Costanzo G,
et al. Effect of cilomilast (Ariflo) on TNF-
a
, IL-8, and GM-CSF release by
airway cells of patients with COPD. Thorax 2003; 58:573-579.
84. Culpitt SV, Rogers DF, Shah P, de Matos C, Russell RE, Donnelly LE, et al.
Impaired inhibition by dexamethasone of cytokine release by alveolar
